AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹246 Cr | ₹230 Cr | ₹208 Cr | ₹183 Cr | ₹211 Cr |
What is the latest Total Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹246 Cr |
Mar2022 | ₹230 Cr |
Mar2021 | ₹208 Cr |
Mar2020 | ₹183 Cr |
Mar2019 | ₹211 Cr |
How is Total Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹246 Cr | 6.82 | |
Mar2022 | ₹230 Cr | 10.72 | |
Mar2021 | ₹208 Cr | 13.52 | |
Mar2020 | ₹183 Cr | -13.19 | |
Mar2019 | ₹211 Cr | - |
Compare Total Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹352.0 Cr | -5.9% | -3.3% | 116.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -5.9% |
-3.3% |
116.3% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses